New hope for advanced cancer? first human trial of BGM-2121 begins
Disease control
Recruiting now
This early-stage study tests a new drug called BGM-2121 in 35 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it helps control the cancer. Participants will receive BG…
Phase: PHASE1 • Sponsor: BioGate Precision Medicine Corp. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC